Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 17.11.2026       Duetti

Duetti has now raised over $1.3 billion since inception in 2022, including three asset-backed securitizations in two years NEW YORK , Nov. 17, 2026 /PRNewswire/ -- Duetti Inc. ("Duetti" or the "Company"), the music company that partners with independent artists, songwriters, and producers to buy, manage, and market their catalogs, announces that it [ … ]
Tue, 17.11.2026       IONOS Group SE

Karlsruhe / Berlin, November 17, 2026. IONOS Group SE has appointed Thomas Saueressig as the new CEO of IONOS Group SE, effective April 1, 2027. Achim Weiß will step down from his position on March 31, 2027. Mr. Saueressig has been a member of the Executive Board of SAP SE and Chief Customer Officer since 2019. He leads the Customer Value Group div [ … ]
Tue, 17.11.2026       Inkera

Newcomer debuts at Formnext 2026 with a UV material-jetting printer offering more than 10 million colors FRANKFURT, Germany, Nov. 17, 2026 /PRNewswire/ -- Inkera, a new name in full-color additive manufacturing, will introduce its first product at Formnext 2026 in Frankfurt. The Inkera C1, a desktop full-color UV 3D printer, will be shown in Hall 1 [ … ]
Tue, 17.11.2026       Mellenu Finance S.A.

PRESS RELEASE NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH PUBLICAT [ … ]
Tue, 17.11.2026       Validix

New patent-pending innovation gives regulated industries traceable and verified AI output. ZUG, Switzerland, Nov. 17, 2026 /PRNewswire/ -- Validix, a company advancing governed claims for enterprise AI, today unveiled its Atomic Claim Architecture, a new patent-pending invention that changes how organizations govern content produced by generative A [ … ]
Tue, 17.11.2026       Deutsche Rohstoff AG

9-month results 2026: EUR 200 million in net income through September   9-month revenue increases by 48% to EUR 221.7 million (previous year: EUR 150.1 million) 9-month EBITDA reaches a record EUR 328.7 million (previous year: EUR 101.7 million) Consolidated net income after minority interests rises to EUR 200.1 million (previous year: EUR 22.0 m [ … ]
Tue, 17.11.2026       GEA Group Aktiengesellschaft

THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUT [ … ]
Tue, 17.11.2026       Tripo AI

The company also unveils an AI agent tailor-made for additive manufacturing, bridging the gap between AI generated content and 3D printers. FRANKFURT AM MAIN, Germany, Nov. 17, 2026 /PRNewswire/ -- At Formnext, Tripo AI offers a glimpse of its upcoming generative model, capable of faithfully reproducing intricate details and visual nuances with exc [ … ]
Tue, 17.11.2026       Sasol Financing USA LLC

Sasol Financing USA LLC 1209 Orange Street Wilmington, DE 19801 United States of America Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014 (pursuant to § 4 I No. 1a WpAV). NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STAT [ … ]
Tue, 17.11.2026       Formycon AG

Press Release // November 17, 2026   Two Blockbusters, Two Niche-Busters, One Smart Portfolio: Formycon Names Tezspire® and Hemlibra® as Reference Drugs   FYB210: biosimilar candidate to tezepelumab (Tezspire®); sales of the reference drug rose by 50 percent to USD 1.9 billion in 2025 FYB286: biosimilar candidate to emicizumab (Hemlibra®); no  [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 22.11.2026, Calendar Week 47, 326th day of the year, 39 days remaining until EoY.